DexCom, Inc. (LON:0A4M)

Market Cap	19.99B
Revenue (ttm)	3.14B
Net Income (ttm)	417.14M
Shares Out	n/a
EPS (ttm)	1.04
PE Ratio	47.92
Forward PE	28.67
Dividend	n/a
Ex-Dividend Date	n/a

Volume	787
Average Volume	6,394
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	65.67 - 90.77
Beta	n/a
RSI	34.75
Earnings Date	Oct 23, 2025

About DexCom

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1999
• Employees: 10,300
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0A4M

Financial Performance

In 2024, DexCom's revenue was $4.03 billion, an increase of 11.34% compared to the previous year's $3.62 billion. Earnings were $576.20 million, an increase of 6.41%.

Financial numbers in USD